Home › Squamous Cell Carcinoma ng Ulo at Leeg › Rhode Island
Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Ulo at Leeg sa Rhode Island
7 pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg ang naghahanap ng mga kalahok sa mga site sa Rhode Island.
Mga Lungsod sa Rhode Island
Opisyal na teksto ng pag-aaral (English)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0132, Providence
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06788990Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Smilow Cancer Hospital Care Center - Westerly, Westerly
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT02734537Head and Neck Cancer Study Project in the Geriatric Population
- Rhode Island and The Miriam Hospitals, Providence
Nagre-recruitPhase 3
Edad 65 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06998069Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04777994A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Women & Infants Hospital, Providence
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT05902988A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Rhode Island Hospital, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2025 · NCT06699212Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Rhode Island Hospital, Providence
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.